Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.Not Yet Recruiting
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +27 more
- A Study of DII235 in Adults With Elevated Lipoprotein(a)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Lipoprotein Disorder
United States, China, Germany, Japan
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Autosomal Recessive Polycystic Kidney (ARPKD)
United States, Belgium, Germany, Poland, Spain +1 more
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Primary Hypercholesterolemiia · Mixed Dyslipidemia
Austria, Belgium, Germany, Italy, Spain
Sponsor: AstraZeneca
B-cell Malignancies
United States, Australia, Canada, China, Denmark +5 more
Sponsor: Akero Therapeutics, Inc
NASH With Fibrosis · MASH With Fibrosis
United States, Argentina, Australia, Canada, France +13 more
Sponsor: Eli Lilly and Company
Metastatic Solid Tumor · Advanced Solid Tumor · Non-small Cell Lung Cancer · SMARCA4-Deficient Tumor
United States, France, Germany, Japan, South Korea +1 more
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
Germany
Sponsor: Merck Sharp & Dohme LLC
Gastroesophageal Junction · Gastroesophageal Adenocarcinoma · Esophageal Neoplasms · Esophageal Cancer
United States, Brazil, Chile, China, France +7 more
Sponsor: BeOne Medicines
CLL · Chronic Lymphocytic Leukemia
United States, Argentina, Australia, Brazil, Canada +9 more
Sponsor: enGene, Inc.
Superficial Bladder Cancer · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ · Non-muscle Invasive Bladder Cancer
United States, Australia, Canada, France, Germany +5 more
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive Not Recruiting
Sponsor: Novo Nordisk A/S
Obesity
United States, Austria, Belgium, Denmark, Germany +5 more
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer · HR+/HER2- Breast Cancer
Germany
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseRecruiting
Sponsor: CRISPR Therapeutics
SLE (Systemic Lupus) · Lupus Erythematosus, Systemic · Lupus Nephritis · Systemic Sclerosis
United States, Germany, Spain
Sponsor: Novartis Pharmaceuticals
C3 Glomerulopathy · Immune-complex-membranoproliferative Glomerulonephritis
United States, Argentina, Brazil, Canada, China +12 more
Sponsor: Penumbra Inc.
Lower Extremity Acute Limb Ischemia · LE ALI
United States, Australia, Brazil, Germany, Italy +1 more
Sponsor: Eli Lilly and Company
Desmoplastic Small Round Cell Tumor
United States, Australia, Germany, Italy, Japan +2 more
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Multiple System Atrophy
United States, France, Germany, Israel, Italy +2 more
Sponsor: LMU Klinikum
Mitochondrial Diseases · Kearns-Sayre Syndrome · MIDD · SANDO
Austria, Germany, Italy
- Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)Active Not Recruiting
Sponsor: BeOne Medicines
CLL
United States, Australia, Austria, Brazil, Canada +16 more
Sponsor: Avalyn Pharma Inc.
Progressive Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)
United States, Argentina, Australia, Canada, Czechia +8 more
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromeActive Not Recruiting
Sponsor: UCB BIOSCIENCES, Inc.
Dravet Syndrome
United States, Belgium, Germany, Italy, United Kingdom
Sponsor: Travere Therapeutics, Inc.
Homocystinuria
United States, Australia, Belgium, France, Germany +9 more
- Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerActive Not Recruiting
Sponsor: AstraZeneca
Endometrial Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
- A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement TherapyActive Not Recruiting
Sponsor: Regeneron Pharmaceuticals
Hemophilia B
United States, Canada, Germany, United Kingdom